Deleterious variants of PARD3 were first detected in neural tube defects, coeliac disease and ulcerative colitis19–21, and subsequently, a series of studies identified the dual function of PARD3 in different malignant tumors of epithelial origin14–18,22–27. This evidence concerns the gene PARD3 and cancer.